Oesophageal Cancer Trial, Recruiting NCT06523374 Sponsor: University Hospital, Antwerp Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06523374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a known condition called Barrett's oesophagus (a change in the lining of the food pipe) and are scheduled for a procedure to investigate or treat a suspected early cancer in the food pipe using a technique to remove tissue (EMR or ESD)
  • People who are able to understand the trial information and agree to take part
  • People aged 18 or older

Who may not be able to join:

  • People who have a known cancer elsewhere in the digestive system (other than the suspected lesion in the food pipe)
  • People with serious health conditions that would make it unsafe to undergo an endoscopy procedure under sedation, such as severe heart or lung disease
  • People who have enlarged veins in the food pipe (oesophageal varices)
  • People with bleeding or clotting disorders that cannot be controlled
  • People who are currently receiving chemotherapy or immunotherapy, or who received chemotherapy within the 6 weeks before the procedure
  • People who are currently receiving radiotherapy to the area around the food pipe, or who received such radiotherapy within 6 months before the procedure
  • People whose overall health and ability to carry out daily activities is rated as very poor, based on a standard medical scale called the WHO performance score (those with a score higher than 3 would not be eligible) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheila Krishnadath, Universitair Ziekenhuis Antwerpen (UZA)

Phone: +3234368281

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Antwerp
Registry
ClinicalTrials.gov
Start date
13 August 2025
Est. completion
1 April 2026

Where this trial is recruiting

🇧🇪 Belgium 🇩🇰 Denmark 🇫🇷 France 🇮🇪 Ireland 🇮🇹 Italy 🇸🇪 Sweden

Primary endpoints

Success rate of brush, biopsy and blood samples obtained from different sites for analysis by HTP technologies; Success rate of DNA-FISH analyses on the brush cytology samples

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov